Global Patent Index - EP 1406662 A1

EP 1406662 A1 20040414 - PHARMACEUTICAL FORMULATION FOR THE INTRAMUSCULAR ADMINISTRATION OF FULVESTRANT

Title (en)

PHARMACEUTICAL FORMULATION FOR THE INTRAMUSCULAR ADMINISTRATION OF FULVESTRANT

Title (de)

PHARMAZEUTISCHE ZUBEREITUNG FÜR DIE INTRAMUSKULÄRE VERABREICHUNG VON FULVESTRANT

Title (fr)

FORMULATION PHARMACEUTIQUE POUR L'ADMINISTRATION INTRAMUSCULAIRE DE FULVESTRANT

Publication

EP 1406662 A1 20040414 (EN)

Application

EP 02740940 A 20020703

Priority

  • GB 0203092 W 20020703
  • GB 0116619 A 20010707
  • US 31571101 P 20010830

Abstract (en)

[origin: WO03006064A1] The invention relates to a sustained release pharmaceutical formulation adapted for administration by injection containing the compound fulvestrant, 7 a-[9-(4,4,5,5,5-pentafluoropentylsulphiny1)nony1]oestra-1,3,5(10)-triene-3,17 ss-diol, at concentration of at least 100mg/ml in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.

IPC 1-7

A61K 47/14; A61K 47/44; A61K 47/10; A61K 31/565

IPC 8 full level

A61K 9/00 (2006.01); A61K 31/565 (2006.01); A61K 47/10 (2006.01); A61K 9/08 (2006.01); A61K 47/14 (2006.01); A61K 47/44 (2006.01); A61P 35/00 (2006.01)

IPC 8 main group level

A61K (2006.01)

CPC (source: EP)

A61K 9/0019 (2013.01); A61K 31/565 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/44 (2013.01); A61P 15/00 (2018.01); A61P 35/00 (2018.01)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

DOCDB simple family (publication)

WO 03006064 A1 20030123; AR 037138 A1 20041027; BR 0210898 A 20040622; CA 2453111 A1 20030123; CN 1553815 A 20041208; CO 5560585 A2 20050930; EP 1406662 A1 20040414; HU P0400115 A2 20040628; HU P0400115 A3 20051128; IL 159576 A0 20040601; IS 7097 A 20040105; JP 2004534093 A 20041111; MX PA04000028 A 20040521; NO 20040047 L 20040223; PL 367624 A1 20050307; RU 2004102393 A 20050327

DOCDB simple family (application)

GB 0203092 W 20020703; AR P020102523 A 20020705; BR 0210898 A 20020703; CA 2453111 A 20020703; CN 02817188 A 20020703; CO 04000761 A 20040107; EP 02740940 A 20020703; HU P0400115 A 20020703; IL 15957602 A 20020703; IS 7097 A 20040105; JP 2003511869 A 20020703; MX PA04000028 A 20040107; NO 20040047 A 20040106; PL 36762402 A 20020703; RU 2004102393 A 20020703